flurbiprofen has been researched along with Liver Dysfunction in 2 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blouin, R | 1 |
| Chaudhary, I | 1 |
| Nishihara, K | 1 |
| Cox, S | 1 |
| Knadler, MP | 1 |
| Brater, DC | 1 |
| Hall, SD | 1 |
2 other studies available for flurbiprofen and Liver Dysfunction
| Article | Year |
|---|---|
The effects of liver and renal disease on stereoselective serum binding of flurbiprofen.
Topics: Adult; Aged; Blood Proteins; Flurbiprofen; Humans; Kidney Diseases; Liver Diseases; Male; Middle Age | 1993 |
Plasma protein binding of flurbiprofen: enantioselectivity and influence of pathophysiological status.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Binding, Competitive; Blood Proteins; Flurbiprofen; Humans; | 1989 |